Sera Prognostics, Inc. (SERA)
2.16
+0.02
(+0.93%)
USD |
NASDAQ |
May 29, 16:00
2.15
-0.01
(-0.46%)
After-Hours: 20:00
Sera Prognostics EPS Diluted (Quarterly) : -0.1671 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Myriad Genetics, Inc. | -0.3639 |
| BioRestorative Therapies, Inc. | -0.1215 |
| CareDx, Inc. | 0.0529 |
| Natera, Inc. | -0.6013 |
| Exagen, Inc. | -0.1663 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -8.399M |
| Revenue (Quarterly) | 0.014M |
| Total Expenses (Quarterly) | 8.413M |
| Enterprise Value | 39.69M |
| Gross Profit Margin (Quarterly) | -1.37K% |
| Profit Margin (Quarterly) | -59.99K% |
| Earnings Yield | -29.94% |
| Normalized Earnings Yield | -29.94 |